Abstract
BACKGROUND AND OBJECTIVES: Non-obstetric causes of pain during pregnancy are very common and can be disabling if not treated properly. The objective of this study is to discuss the pharmacological treatment of pain during pregnancy with a focus on drug classification and pregnancy use, therapy options, teratogenicity, increased fetal malformations and gestational complications associated with the use of therapy CONTENTS: During pregnancy, the body goes through several anatomical and physiological changes. These changes can precipitate pain, which in some cases can lead to disability. In addition, pregnancy may exacerbate pre-existing painful conditions. The choice to prescribe a drug to a pregnant woman is difficult. The changes in the body of a pregnant woman influence drug absorption, distribution, metabolism, and excretion, and may alter the expected response. CONCLUSION: The risks and benefits of the drug for the mother and the child should be considered, weighing the risks of not treating the disease adequately during pregnancy.
Highlights
During pregnancy, non-obstetric causes of pain are very common and can be disabling if not properly treated
The goal of this research was to discuss the pharmacological treatment of pain during pregnancy, focusing on drug classification and usage in pregnancy, therapy options, teratogenicity, increase in fetal malformations, and gestational complications associated with therapy use
In order to avoid the administration of drugs with potential risk and to facilitate their prescription during pregnancy, several classification systems based on animal and human data have been developed
Summary
Non-obstetric causes of pain are very common and can be disabling if not properly treated. Many anatomical and physiological changes take place in the body These changes can precipitate pain, which, in some cases, can lead to disability. The changes in the body of a pregnant woman influence the absorption, distribution, metabolism, and excretion of drugs, and may change the expected response. It should be considered the risks and benefits for both the mother and the child when using the drug, considering the risks of not treating properly the disease during pregnancy and lactation. The goal of this research was to discuss the pharmacological treatment of pain during pregnancy, focusing on drug classification and usage in pregnancy, therapy options, teratogenicity, increase in fetal malformations, and gestational complications associated with therapy use. The most relevant articles on the topic were selected and included in the paper
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
